Building Immunity Building Trust
Vaccines for a Healthier World
WE INVENT FOR LIFE
“We are committed to improve global health by utilising the latest scientific research to tackle the world’s greatest health threats”
Fighting against chronic inflamatory diseases
“Building Immunity Building Trust: Vaccines for a Healthier World”
Changing the world is possible. We’ve done it before.
Vision Statement
“Redefining healthcare through pioneering solutions and research excellence, empowering a world where proactive prevention and personalized care lead to healthier, longer lives.”
Mission Statement
“To push the boundaries of scientific discovery, transforming healthcare with cutting-edge innovations and empowering individuals with the tools and knowledge to take charge of their well-being, ultimately creating a future where preventable diseases are minimized, and health is personalized.”
Advanced Vaccine Solutions
for a Healthier Tomorrow
Advanced Vaccine Solutions for a Healthier Tomorrow
KITS
Inflanova is a leader in groundbreaking diagnostic solutions, empowering healthcare professionals to deliver faster, more accurate diagnoses and personalized treatment plans for their patients.
Read More
Vaccines
Harnessing cutting-edge technology and extensive research, our Vaccine represents a paradigm shift in healthcare.
Read More
Precision Medicine
Our solutions enable early and accurate disease detection, allowing for the development of customized treatment plans that address individual needs and optimize health outcomes.
Read More
What People Say
Dr. Shailesh Kumar Samal
Co-Founder and CEO, Inflanova AB
Dr. Shailesh Kumar Samal is a leading authority in immunotherapy and biotechnology, with dual Ph.D. degrees in Medical Sciences from Karolinska Institutet and Biochemistry from Maastricht University.
Dr. Shailesh Kumar Samal
Co-Founder and CEO, Inflanova AB
Dr. Shailesh Kumar Samal is a leading authority in immunotherapy and biotechnology, with dual Ph.D. degrees in Medical Sciences from Karolinska Institutet and Biochemistry from Maastricht University.
Dr. Shailesh Kumar Samal
Co-Founder and CEO, Inflanova AB
Dr. Shailesh Kumar Samal is a leading authority in immunotherapy and biotechnology, with dual Ph.D. degrees in Medical Sciences from Karolinska Institutet and Biochemistry from Maastricht University.
Inflanova’s dedication to personalized healthcare and early detection through diagnostic tools is a step in the right direction for modern medicine
Dr Nobuyo Maeda
Robert H Wagner Distinguished Professor, Department of Pathology and Laboratory Medicine,
University of North Carolina – Chapel Hill, USA
University of North Carolina – Chapel Hill, USA
(A distinguished geneticist and medical researcher, who works on complex human diseases including atherosclerosis, diabetes and high blood pressure, and is particularly known for creating the first mouse model for atherosclerosis)
Inflanova is leading the change in healthcare transformation. Their innovative approach to vaccines is changing the landscape of medicine for the better.
Prof Dr Tilman Hackeng
(T.M.) Director, Cardiovascular Research Institute (CARIM), Maastricht University, Netherlands
Inflanova’s innovative vaccines are a breath of fresh air in the fight against chronic inflammation. Their dedication to improving global health is evident in their cutting-edge research and development.
Dr. Sachin Kote
Group Leader, Clinical Peptidomics Group, International Centre for Cancer Vaccine Science,
University of Gdańsk, Poland
University of Gdańsk, Poland
As someone who has seen the toll inflammatory diseases can take, Inflanova’s work is nothing short of a miracle. They’re not just developing vaccines but giving hope to millions of families worldwide.
Prof Leon Schurgers
CARIM School for Cardiovascular Diseases, Maastricht University
Inflanova’s integration of AI in their research and development process is not just smart; it’s essential. In a world where diseases evolve rapidly, adapting and innovating quickly is crucial. Inflanova is leading the charge, and it’s a thrilling time to be part of their journey.
Prof Karl Andersson
Professor and Head of Subject, Dean, Computer Science, Department of Computer Science,
Electrical and Space Engineering, Lulea University of Technology, Sweden
Electrical and Space Engineering, Lulea University of Technology, Sweden
The Power of Our Progress
Patents
0
+
Publications
0
+
Collaborations
0
+
Building Immunity, Building Trust :
Vaccines for a Healthier World
Inflanova AB is a vaccine development company committed to addressing chronic inflammatory diseases and viral infections through innovative science. Founded by Dr. Shailesh Kumar Samal and Dr. Johan Frostegård, our mission is to transform healthcare with vaccines that go beyond conventional approaches, offering protection against both immediate and long-term health threats.
With a commitment to improving global health, Inflanova AB is at the forefront of vaccine innovation, working to reduce the burden of chronic inflammatory diseases and viral infections, and helping people live healthier, longer lives.
With a commitment to improving global health, Inflanova AB is at the forefront of vaccine innovation, working to reduce the burden of chronic inflammatory diseases and viral infections, and helping people live healthier, longer lives.
Building Immunity, Building Trust :
Vaccines for a Healthier World
Inflanova AB is a vaccine development company committed to addressing chronic inflammatory diseases and viral infections through innovative science. Founded by Dr. Shailesh Kumar Samal and Dr. Johan Frostegård, our mission is to transform healthcare with vaccines that go beyond conventional approaches, offering protection against both immediate and long-term health threats.
With a commitment to improving global health, Inflanova AB is at the forefront of vaccine innovation, working to reduce the burden of chronic inflammatory diseases and viral infections, and helping people live healthier, longer lives.
With a commitment to improving global health, Inflanova AB is at the forefront of vaccine innovation, working to reduce the burden of chronic inflammatory diseases and viral infections, and helping people live healthier, longer lives.
“Building Immunity,
Building Trust : Vaccines for a
Healthier World”
Live Your Life Now To Secure
Future Generations
Join us in our fight against disease and create a healthier world
Our Blogs Service With Us.
Lorem Ipsum is simply dummy text of the printing.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum is simply dummy text of the printing.
Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor.
Company Founder Details.
Dr. Shailesh Kumar Samal
Co-Founder and CEO,
Inflanova AB
Dr. Shailesh Kumar Samal is an accomplished expert in immunotherapy and biotechnology, with dual Ph.D. degrees in Medical Sciences from Karolinska Institutet and Biochemistry from Maastricht University.
Prof. Johan Frostegård
Co-Founder and Chairman,
Inflanova AB
Prof. Johan Frostegård, a distinguished researcher and physician, leads the Unit of Immunology and Chronic Disease at Karolinska Institutet. His research focuses on the immune system’s role in cardiovascular diseases.
The Power of Our Team
Indian Address
KIIT-Technology Business Incubator
Campus 11, KIIT-DU, Bhubaneswar, Odisha, INDIA 751024
Swedish Address
Karlbergsvägen 40 lgh 1401, 113 27 Stockholm
